Clinical trial
A Phase 2 Open-Label, Parallel Group, Randomized, Dose-Finding Study to Assess the Efficacy and Safety of Intercostal SKY0402 in Subjects Undergoing Posterolateral Thoracotomy
NCT00807209 is registered in ClinicalTrials.gov with Pacira Pharmaceuticals, Inc as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Open-Label, Parallel Group, Randomized, Dose-Finding Study to Assess the Efficacy and Safety of Intercostal SKY0402 in Subjects Undergoing Posterolateral Thoracotomy
- Lead sponsor
- Pacira Pharmaceuticals, Inc
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- December 31, 2008
- Completion date
- February 28, 2009
- Enrollment
- 3 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.